Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-06

Clinical Trial Update: Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Dihydropyridine Calcium Channel Blockers Versus Hydrochlorothiazide

View source ↗

Summary

Brigham and Women's Hospital completed a trial analyzing repurposing potential of dihydropyridine calcium channel blockers for Alzheimer's disease, comparing th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dihydropyridine calcium channel blockers
  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Hypertension | Status: COMPLETED | Results posted: 2025-11-06